Statera Biopharma, Inc. (STAB)
OTCMKTS: STAB · Delayed Price · USD
0.0007
0.00 (0.00%)
Apr 25, 2024, 1:31 PM EDT - Market closed
Statera Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 0 | 81 | 88 | 15 | 11 | 45 | 16 | 25 | 15,406 | 1,053,066 | 994,543 | Upgrade
|
| Market Cap Growth | - | -8.74% | 473.09% | 35.37% | -74.58% | 187.66% | -36.68% | -99.84% | -98.54% | 5.88% | -46.60% | Upgrade
|
| Enterprise Value | 7 | 95 | 90 | 17 | 8 | 41 | 9 | 19 | 21,261 | 1,050,230 | 969,061 | Upgrade
|
| PE Ratio | -0.32 | -0.46 | -6.69 | -4.61 | -3.16 | -4.62 | -5.87 | -1.95 | 9.46 | -61.00 | -54.54 | Upgrade
|
| PS Ratio | 0.01 | - | - | - | - | - | - | - | - | - | - | Upgrade
|
| PB Ratio | -0.64 | -51.50 | -24.21 | -3.67 | -7.86 | 20.40 | 2.07 | 2.49 | -15.35 | -110.58 | 157.04 | Upgrade
|
| P/FCF Ratio | -0.50 | -2.85 | -17.38 | -64.24 | -2.47 | -6.79 | -3.10 | -2.04 | -1.07 | -45.58 | -48.16 | Upgrade
|
| P/OCF Ratio | -0.51 | -2.86 | -17.41 | -64.24 | -2.47 | -6.79 | -3.10 | -2.04 | -1.07 | -45.58 | -48.16 | Upgrade
|
| EV/Sales Ratio | 1.88 | - | - | - | - | - | - | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 0.15 | 2.44 | -8.56 | -6.13 | -1.62 | -7.26 | -1.37 | -1.73 | -1.47 | -45.51 | -32.25 | Upgrade
|
| EV/EBIT Ratio | 0.15 | 2.46 | -8.56 | -6.10 | -1.62 | -7.23 | -1.36 | -1.71 | -1.45 | -44.78 | -31.75 | Upgrade
|
| EV/FCF Ratio | -1.04 | -3.35 | -17.66 | -71.74 | -1.69 | -6.15 | -1.73 | -1.55 | -1.47 | -45.46 | -46.93 | Upgrade
|
| Debt / Equity Ratio | -0.72 | -10.37 | -0.55 | -0.43 | 0 | 0 | 0 | 0 | -7.30 | -0.76 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.16 | 0.42 | -0.19 | -0.64 | - | - | - | - | -0.51 | -0.31 | -0.01 | Upgrade
|
| Debt / FCF Ratio | -0.57 | -0.57 | -0.39 | -7.51 | - | - | - | - | -0.51 | -0.31 | -0.01 | Upgrade
|
| Quick Ratio | 0.04 | 0.21 | 0.20 | 0.20 | 4.80 | 4.22 | 5.02 | 3.47 | -1.17 | 1.81 | 2.48 | Upgrade
|
| Current Ratio | 0.05 | 0.37 | 0.20 | 0.00 | 4.91 | 4.33 | 5.11 | 3.54 | -1.17 | 1.86 | 2.57 | Upgrade
|
| Asset Turnover | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Coverage | -0.85 | -8.48 | -9.29 | -22.65 | 0 | 0 | -24.11 | 108.47 | 13.24 | -277.61 | 429.15 | Upgrade
|
| Return on Equity (ROE) | 931.78% | 11122.70% | 361.75% | 79.53% | 248.77% | -441.26% | -35.34% | -127.81% | -162.30% | 181.28% | -287.92% | Upgrade
|
| Return on Assets (ROA) | -748.49% | -823.86% | -1277.14% | -202924.55% | -79.66% | -100.80% | -16.66% | -60.52% | 45.92% | -117.47% | -56.96% | Upgrade
|
| Return on Capital (ROIC) | 3110.92% | 263.25% | 635.55% | 117.00% | 330.58% | -254.61% | -84.47% | -109.13% | -228.05% | 998.82% | -462.08% | Upgrade
|
| Earnings Yield | -190887.38% | -215.98% | -14.94% | -21.68% | -31.67% | -21.63% | -17.04% | -51.29% | 10.57% | -1.64% | -1.83% | Upgrade
|
| FCF Yield | -25932.62% | -35.14% | -5.75% | -1.56% | -40.44% | -14.73% | -32.30% | -49.02% | -93.83% | -2.19% | -2.08% | Upgrade
|
| Buyback Yield / Dilution | -85.80% | -36.88% | - | -127.11% | -0.91% | -1.87% | -55.62% | 99.74% | 93.99% | -20.36% | -14.82% | Upgrade
|
| Total Shareholder Return | -85.80% | -36.88% | - | -127.11% | -0.91% | -1.87% | -55.62% | 99.74% | 93.99% | -20.36% | -14.82% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.